-
Je něco špatně v tomto záznamu ?
The interplay between microbiome and host factors in pathogenesis and therapy of head and neck cancer
M. Raudenská, M. Bugajová, D. Kalfeřt, J. Plzák, A. Šubrt, P. Tesařová, M. Masařík
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, přehledy
- MeSH
- dlaždicobuněčné karcinomy hlavy a krku * mikrobiologie patologie imunologie terapie MeSH
- lidé MeSH
- nádorové mikroprostředí * imunologie MeSH
- nádory hlavy a krku * imunologie mikrobiologie patologie terapie MeSH
- střevní mikroflóra * imunologie MeSH
- životní styl MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Heterogeneous cancers that lack strong driver mutations with high penetrance, such as head and neck squamous cell carcinoma (HNSCC), present unique challenges to understanding their aetiology due to the complex interactions between genetics and environmental factors. The interplay between lifestyle factors (such as poor oral hygiene, smoking, or alcohol consumption), the oral and gut microbiome, and host genetics appears particularly important in the context of HNSCC. The complex interplay between the gut microbiota and cancer treatment outcomes has also received increasing attention in recent years. This review article describes the bidirectional communication between the host and the oral/gut microbiome, focusing on microbiome-derived metabolites and their impact on systemic immune responses and the modulation of the tumour microenvironment. In addition, we review the role of host lifestyle factors in shaping the composition of the oral/gut microbiota and its impact on cancer progression and therapy. Overall, this review highlights the rationality of considering the oral/gut microbiota as a critical determinant of cancer therapy outcomes and points to therapeutic opportunities offered by targeting the oral/gut microbiota in the management of HNSCC.
Department of Physiology Faculty of Medicine Masaryk University Kamenice 5 62500 Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno 60200 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003553
- 003
- CZ-PrNML
- 005
- 20250206104416.0
- 007
- ta
- 008
- 250121s2024 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bbcan.2024.189216 $2 doi
- 035 __
- $a (PubMed)39542383
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Raudenská, Martina $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University/Kamenice 5, CZ-625 00 Brno, Czech Republic; Department of Physiology, Faculty of Medicine, Masaryk University/Kamenice 5, 62500 Brno, Czech Republic
- 245 14
- $a The interplay between microbiome and host factors in pathogenesis and therapy of head and neck cancer / $c M. Raudenská, M. Bugajová, D. Kalfeřt, J. Plzák, A. Šubrt, P. Tesařová, M. Masařík
- 520 9_
- $a Heterogeneous cancers that lack strong driver mutations with high penetrance, such as head and neck squamous cell carcinoma (HNSCC), present unique challenges to understanding their aetiology due to the complex interactions between genetics and environmental factors. The interplay between lifestyle factors (such as poor oral hygiene, smoking, or alcohol consumption), the oral and gut microbiome, and host genetics appears particularly important in the context of HNSCC. The complex interplay between the gut microbiota and cancer treatment outcomes has also received increasing attention in recent years. This review article describes the bidirectional communication between the host and the oral/gut microbiome, focusing on microbiome-derived metabolites and their impact on systemic immune responses and the modulation of the tumour microenvironment. In addition, we review the role of host lifestyle factors in shaping the composition of the oral/gut microbiota and its impact on cancer progression and therapy. Overall, this review highlights the rationality of considering the oral/gut microbiota as a critical determinant of cancer therapy outcomes and points to therapeutic opportunities offered by targeting the oral/gut microbiota in the management of HNSCC.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a střevní mikroflóra $x imunologie $7 D000069196
- 650 12
- $a nádory hlavy a krku $x imunologie $x mikrobiologie $x patologie $x terapie $7 D006258
- 650 _2
- $a životní styl $7 D008019
- 650 12
- $a dlaždicobuněčné karcinomy hlavy a krku $x mikrobiologie $x patologie $x imunologie $x terapie $7 D000077195
- 650 12
- $a nádorové mikroprostředí $x imunologie $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bugajová, Maria $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University/Kamenice 5, CZ-625 00 Brno, Czech Republic
- 700 1_
- $a Kalfeřt, David $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Motol, First Faculty of Medicine, Charles University, V Uvalu 84, 15006 Prague, Czech Republic
- 700 1_
- $a Plzák, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Motol, First Faculty of Medicine, Charles University, V Uvalu 84, 15006 Prague, Czech Republic
- 700 1_
- $a Šubrt, Adam $u Department of Oncology, Institute of Radiation Oncology, First Faculty of Medicine, Charles University and Bulovka University Hospital, Prague, Czech Republic
- 700 1_
- $a Tesařová, Petra $u Department of Oncology, Institute of Radiation Oncology, First Faculty of Medicine, Charles University and Bulovka University Hospital, Prague, Czech Republic
- 700 1_
- $a Masařík, Michal $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University/Kamenice 5, CZ-625 00 Brno, Czech Republic; Department of Physiology, Faculty of Medicine, Masaryk University/Kamenice 5, 62500 Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno 60200, Czech Republic; Institute of Pathophysiology, First Faculty of Medicine, Charles University, U Nemocnice 5, CZ-128 53 Prague, Czech Republic. Electronic address: masarik@med.muni.cz
- 773 0_
- $w MED00000723 $t Biochimica et biophysica acta, CR. Reviews on cancer $x 1879-2561 $g Roč. 1879, č. 6 (2024), s. 189216
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39542383 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104412 $b ABA008
- 999 __
- $a ok $b bmc $g 2263355 $s 1239560
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 1879 $c 6 $d 189216 $e 20241113 $i 1879-2561 $m Biochimica et biophysica acta, CR. Reviews on cancer $n Biochim Biophys Acta Rev Cancer $x MED00000723
- LZP __
- $a Pubmed-20250121